Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates

Hemodialysis International

Volumn 10, Issue SUPPL. 2, 2006, Pages

  Elsharkawy, Magdy M ^a,b   Youssef, Abla M ^a   Zayoon, Mohammed Y ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

Hemodialysis; Hypotension; Intradialytic changes; Magnesium; Parathyroid hormone

Indexed keywords

ACETIC ACID; BICARBONATE; CALCIUM; CREATININE; ELECTROLYTE; HEMOGLOBIN; MAGNESIUM; PARATHYROID HORMONE; PHOSPHORUS; SERUM ALBUMIN; UREA;

ADULT; ALBUMIN BLOOD LEVEL; ANAMNESIS; ARTIFICIAL KIDNEY; BLOOD PH; CACHEXIA; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIALYSATE; DIETARY INTAKE; DRUG USE; DRY WEIGHT; ELECTROCARDIOGRAM; FEMALE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; HYPOTENSION; LABORATORY TEST; LIVER DISEASE; LONG TERM CARE; MAGNESIUM BLOOD LEVEL; MALE; NEOPLASM; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; STATISTICAL SIGNIFICANCE; UREA NITROGEN BLOOD LEVEL;

ACETATES; ADULT; BICARBONATES; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD UREA NITROGEN; CREATININE; DIALYSIS SOLUTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTENSION; KIDNEY FAILURE, CHRONIC; MAGNESIUM; MALE; MIDDLE AGED; POTASSIUM; RENAL DIALYSIS; RISK FACTORS; SERUM ALBUMIN; SODIUM; TREATMENT OUTCOME;

EID: 33749321285     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2006.00120.x     Document Type: Conference Paper

References (21)

1. Navarro JF, Mora C, Jimenez A, Torres A, Macia M, Garcia J. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis. 1999; 34: 43-48.
2. Fox C, Ramsoomair D, Carter C. Magnesium: Its proven and potential clinical significance. South Med J. 2001; 94: 1195-1201.
3. Mountokalakis TD. Magnesium metabolism in chronic renal failure (review). Magnes Res. 1990; 3: 121-127.
4. Navarro-Gonzalez JF. Magnesium in dialysis patients: Serum levels and clinical implications. Clin Nephrol. 1998; 49: 373-378.
5. Lindeman RD. Chronic renal failure and magnesium metabolism. Magnesium. 1986; 5: 293-300.
6. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system: I. Clinical aspects (review). Magnesium. 1985; 4: 226-244.
7. 2+ and vascular contractility (review). Miner Electrolyte Metab. 1993; 19: 323-336.
8. Shechter M, Merz CN, Paul-Labrador M, et al. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Am J Cardiol. 1999; 84: 152-156.
9. Baxter GF, Sumeray MS, Walker JM. Infarct size and magnesium: Insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet. 1996; 348: 1424-1426.
10. Senft V, Racek J, Motan J, Krizek M, Bejckova H, Kohout J. An evaluation of the influence of therapeutic interventions on serum trace element levels in groups of patients. J Trace Elem Med Biol. 2003; 17: 7-11.
11. Bregman H, Daugirdas JT, Ing TS. Complications during hemodialysis. In: Daugirdas JT, Blake PG, Ing TS eds. Handbook of Dialysis. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2001: 148-168.
12. Jahn H, Schohn D, Schmitt R. Hemodynamic studies in chronic terminal renal insufficiency - Effects of hemodialysis (HD), hemofiltration (HF) and ultrafiltration (UF) procedures (author's transl). Nephrologie. 1981; 2 (2): 53-62.
13. Martin KJ, Gonzalez EA, Gellens ME, Hamm LL, Abboud H, Lindberg J. Therapy of secondary hyperparathyroidism with 19-nor-1alpha, 25-dihydroxyvitamin D2. Am J Kidney Dis. 1998; 32 (Suppl. 2): S61-S66.
14. Magyar C, Peter A, Friedman M. Renal regulation of calcium phosphorus and magnesium. Acid-Base Electrolyte Disorders. 2002.
15. Navarro JF, Macia ML, Gallego E, et al. Serum magnesium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for adynamic bone disease? Scand J Urol Nephrol. 1997; 31: 275-280.
16. Sanford R, Gonzalez EA, Martin KJ. Abnormal Ca and Mg metabolism. Acid-Base Electrolyte Disorders. 2002.
17. Philipe G, Eric E, Simon A, Jacob L. Acidosis of chronic renal failure. Acid-Base Electrolyte Disorders. 2002.
18. Cho MS, Lee KS, Lee YK, et al. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Korean J Intern Med. 2002; 17: 114-121.
19. Altura BM, Altura BT, et al. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system: I. Clinical aspects. Magnesium. 1985; 4: 226-244.
20. Yokoyama A, Kikuchi K, Kawamura Y, et al. Heart rate variability, arrhythmia and magnesium in hemodialysis patients. Review, (Japanese) Clin Calcium. 2005; 15: 226-232.
21. Kyriazis J, Kalogeropoulou K, Bilirakis L, et al. Dialysate magnesium level and blood pressure. Kidney Int. 2004; 66: 1221-1231.